Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mental Injuries Roadmap
Tammy Bradly was featured in this month’s Business Insurance, discussing "The Winding Road for Mental Health Claims." This piece explores the changing landscape of mental health claim approvals in workers’ compensation.
Ask The Pharmacist: Understanding the Different Types of Drug Recalls
Drugs can be withdrawn from the market for a number of reasons, ranging from minor labeling errors to the potential risk of severe health consequences. The process behind these recalls are diverse but essential for safeguarding public health.
Home Health Cheat Sheet
Workers’ compensation cases resulting in the need for home health care require specialized expertise to provide a seamless and customized transition of care. Whether an individual requires simple or complex home health, Apricus leverages a strong national network of credentialed home health care providers to coordinate the appropriate level of care for each injured employee, in a timely and compassionate manner.
Beyond Labels – Mental Health Language Decoded
Tammy Bradly offers an insightful analysis of the distinctions between mental health, mental illness, and behavioral health, shedding light on frequently overlooked subtleties.
Enlyte Drug Trends Report Indicates Significant Drop of Opioid Use in Comp
Efforts by workers’ comp regulators and professionals to control opioid prescriptions and distribution are resulting in one of the largest drops in utilization the workers’ comp industry has seen in years, according to researchers who published part one of Enlyte’s 2024 Annual Pharmacy Solutions Drug Trends Report today.
Enlyte and Mitchell Honored as American Business Awards® Winners
Enlyte and Mitchell, an Enlyte company, have been recognized by the American Business Association with two prestigious Stevie® awards for excellence. This recognition underscores the organizations’ commitment to leveraging their comprehensive data and market expertise to serve the needs of the property and casualty industry.